Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2026-02-25 @ 4:48 PM
Study NCT ID:
NCT05643794
Status:
COMPLETED
Last Update Posted:
2025-07-01
First Post:
2022-11-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia Syndrome
Sponsor:
UCB Biopharma SRL
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-21
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-09
Completion Date Type:
ACTUAL
First Submit Date:
2022-11-30
First Submit QC Date:
None
Study First Post Date:
2022-12-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-05-21
Results First Submit QC Date:
None
Results First Post Date:
2025-07-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-26
Last Update Post Date:
2025-07-01
Last Update Post Date Type:
ACTUAL